×

Eli Lilly drops CVS drug plan for workers after Novo obesity deal, Bloomberg News reports

By Thomson Reuters Nov 11, 2025 | 8:34 PM

(Reuters) -Eli Lilly is dropping CVS Health’s drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk, Bloomberg News reported on Tuesday, citing people familiar with the matter.

Beginning on January 1, Lilly employees covered by the company’s medical plan will automatically be enrolled with pharmacy benefit coverage through a privately held pharmacy benefit manager called Rightway, Bloomberg said, citing a document viewed by them.

Reuters could not immediately verify the Bloomberg report.

(Reporting by Rishabh Jaiswal in Bengaluru)